“I worked a lot with Varun in my role of IT program lead for Global Transparency in Novartis. Varun is a special person, he's very well knowledgeable on business topics and able to bridge and create connection with the IT world but also showing strong empathy and human connection with the teams he's working with. It has always been a pleasure to work with him for high quality of his deliverables as well as the simple positive and good behavior.”
About
A passionate problem solver engaged as a consultant. I have close to 7 years of…
Activity
-
🎨✨ Guess who just joined the cool club? ✨🎨 I am thrilled and proud to announce that I have been recognized as a Top Voice in UX on LinkedIn! 🎉💼…
🎨✨ Guess who just joined the cool club? ✨🎨 I am thrilled and proud to announce that I have been recognized as a Top Voice in UX on LinkedIn! 🎉💼…
Liked by Varun Reddy Thummala
-
Ongoing tension between the boss and employee who refused to attend calls/emails after office hours 😆
Ongoing tension between the boss and employee who refused to attend calls/emails after office hours 😆
Liked by Varun Reddy Thummala
-
Today we announced that the FDA granted #BreakthroughTherapyDesignation to our investigational treatment regimen for people with PIK3CA-mutated…
Today we announced that the FDA granted #BreakthroughTherapyDesignation to our investigational treatment regimen for people with PIK3CA-mutated…
Liked by Varun Reddy Thummala
Experience
Education
Licenses & Certifications
Publications
-
Tapping the Regulatory Hurdles of Biosimilars: Marketing Authorization across European Union
Indian Journal of Applied Research
-
Development of Highly Porous Gastroretentive Dipyridamole Tablets Using a Sublimation Method
Indo American Journal of Pharmaceutical Sciences
Honors & Awards
-
Unique Professional Award 2023
Association of Pharmacy Professionals
-
Impressive Engagement
WNS
-
Star Award
Product lifecycle services, Novartis
-
Star Award
Product lifecycle services, Novartis
-
Applause Award
Product lifecycle services, Novartis
-
Applause Award
Product lifecycle services, Novartis
-
Applause Award
Product lifecycle services, Novartis
-
Applause Award
Product lifecycle services, Novartis
Recommendations received
4 people have recommended Varun Reddy
Join now to viewMore activity by Varun Reddy
-
🎈The day of layoffs. The worst day of my life. Here is why. Our start-up was running out of money. Either we laid off 50% of employees, or 100%…
🎈The day of layoffs. The worst day of my life. Here is why. Our start-up was running out of money. Either we laid off 50% of employees, or 100%…
Liked by Varun Reddy Thummala
-
Today's Shootout: Dr. Seema Mehta Professor Dr. Seema Mehta has 22 years of experience in Teaching, Training, and Research in the field of…
Today's Shootout: Dr. Seema Mehta Professor Dr. Seema Mehta has 22 years of experience in Teaching, Training, and Research in the field of…
Liked by Varun Reddy Thummala
-
Dear all, Many of you will know that I've been living with Bowel (Colorectal) cancer for the last 3 years. During that time a number of us have…
Dear all, Many of you will know that I've been living with Bowel (Colorectal) cancer for the last 3 years. During that time a number of us have…
Liked by Varun Reddy Thummala
-
Pharmarack's latest research reveals how Indian drug manufacturers are leveraging flagship products, or "mother brands," to pioneer new combinations…
Pharmarack's latest research reveals how Indian drug manufacturers are leveraging flagship products, or "mother brands," to pioneer new combinations…
Liked by Varun Reddy Thummala
-
BREAKING: The FDA has approved mirvetuximab soravtansine-gynx (Elahere) for adult patients with FRα-positive, platinum-resistant epithelial ovarian…
BREAKING: The FDA has approved mirvetuximab soravtansine-gynx (Elahere) for adult patients with FRα-positive, platinum-resistant epithelial ovarian…
Liked by Varun Reddy Thummala
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More